查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614077

ELISpot 和 FluoroSpot 检测市场：按产品、应用和最终用户 - 2025-2030 年全球预测

ELISpot & FluoroSpot Assay Market by Product (Acessories, Analyzers, Assay Kits), Application (Autoimmune Disorders, Infectious Diseases, Oncology), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年 ELISpot 和 FluoroSpot 检测市值为 2.9268 亿美元，预计到 2024 年将达到 3.1361 亿美元，复合年增长率为 7.02%，预计到 2030 年将达到 4.7074 亿美元。

ELISpot（酶联免疫点）和 FluoroSpot 测定是重要的免疫学工具，广泛用于研究和临床环境中，用于测量单细胞水平上细胞激素分泌细胞的频率。这些测定提供了免疫反应的灵敏且特异性的定量分析，在疫苗开发、癌症免疫治疗以及感染疾病和自体免疫疾病的研究中非常有用。对这些测定的需求源于它们能够深入了解免疫状态、识别保护的免疫相关性以及协助疫苗功效研究。主要应用是免疫学研究、製药公司和临床诊断实验室，它们是试剂、耗材和检测试剂套件的主要市场。

主要市场统计
基准年[2023] 2.9268亿美元
预测年份 [2024] 31361万美元
预测年份 [2030] 47074万美元
复合年增长率（%） 7.02%

免疫疗法和疫苗开发的研发活动不断增加、医疗保健支出增加以及政府支持生命科学研究的有利倡议推动了市场成长。提高检测灵敏度和通量的生物技术进步以及自动化等技术改进是关键驱动因素。然而，主要的限制包括检测的高成本、对专业技能的需求以及初始设置成本，这些可能对市场渗透造成障碍，特别是在新兴国家。

潜在的机会使公司能够专注于提供具有成本效益的高通量检测解决方案，并开发资料分析软体，以提高易用性和准确性。与研究机构和生物製药公司的策略联盟可以增强您的市场地位。创新将针对能够同时检测多种细胞激素的多重检测，而这种需求不断增加。

这个市场呈现出个人化医疗的趋势，需要针对个别患者的免疫状况进行创新。成功的关键在于持续的技术进步和旨在克服成本和技术障碍的策略市场定位，从而确保广泛采用和持续成长。理想情况下，公司投资研发以提高准确性、降低成本并管理生物复杂性，以便提供符合市场需求和技术进步的产品。

市场动态：揭示快速发展的 ELISpot 和 FluoroSpot 分析市场的关键市场见解

ELISpot 和 FluoroSpot 侦测市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 慢性病及感染疾病率增加
    • 对免疫疗法和个人化药物的需求不断增长
    • 由于免疫监测研究的增加，使用量增加
  • 市场限制因素
    • 测量通讯协定的复杂性和可变性
  • 市场机会
    • 使用者友善高通量检测系统的开发进展
    • ELISpot 和 FluoroSpot 检测在兽医应用中的巨大潜力
  • 市场挑战
    • eLISpot 和 florSpot 测定解释和资料分析的复杂性

波特五力：开拓 ELISpot 与 FluoroSpot 检测市场的策略工具

波特的五力框架是了解 ELISpot 和 FluoroSpot 侦测市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 ELISpot 和 FluoroSpot 分析市场的外部影响

外部宏观环境因素在塑造 ELISpot 和 FluoroSpot 检测市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解 ELISpot 和 FluoroSpot 侦测市场的竞争格局

对 ELISpot 和 FluoroSpot 检测市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 ELISpot 与 FluoroSpot 侦测市场供应商的绩效评估

FPNV 定位矩阵是评估 ELISpot 和 FluoroSpot 侦测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製 ELISpot 和 FluoroSpot 检测市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 ELISpot 和 FluoroSpot 分析市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病及感染疾病率增加
      • 对免疫疗法和个人化医疗的需求不断增长
      • 由于免疫监测研究的增加，使用量增加
    • 抑制因素
      • 检测通讯协定的复杂性和可变性
    • 机会
      • 使用者友善高通量检测系统的开发进展
      • ELISpot 和 FluoroSpot 检测在兽医应用中的巨大潜力
    • 任务
      • eLISpot 和 florSpot 侦测解释和资料分析的复杂性
  • 市场区隔分析
    • 产品：综合检测试剂套件在研究机构和实验室中日益普及
    • 应用：扩大政府努力推动肿瘤学研究、诊断和治疗
    • 最终用户：在研究和临床实践中使用 ELISpot 和 FluoroSpot 检测可提供前所未有的精确度和可靠结果。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章 ELISpot 和 FluoroSpot 检测市场：按产品

  • 配件
  • 分析仪
  • 检测试剂套件

第 7 章 ELISpot 与 FluoroSpot 侦测市场：按应用分类

  • 自体免疫疾病
  • 感染疾病
  • 肿瘤学
  • 器官移植
  • 疫苗开发

第 8 章 ELISpot 和 FluoroSpot 检测市场：按最终用户划分

  • 学术研究所
  • 医院和临床实验室

第九章美洲ELISpot与FluoroSpot分析市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区ELISpot与FluoroSpot分析市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的 ELISpot 和 FluoroSpot 检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Singamani 开发先进的蛋白质成像方法
    • Celerion 扩展服务范围，包括符合 GLP/GCP 的分子生物学和细胞生物学测试
    • PerkinElmer 的 OxfordImmunotec 获得美国FDA核准用于 T 细胞选择，以实现临床上卓越的结核病自动检测
  • 战略分析和建议

公司名单

  • Abcam PLC
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Anogen-Yes Biotech Laboratories Ltd
  • Autoimmun Diagnostika GmbH
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • BIOSYS Scientific Devices GmbH
  • BOC Sciences
  • Broughton Life Sciences Limited
  • CellCarta Biosciences Inc.
  • Creative Proteomics
  • Elabscience
  • Full Moon BioSystems, Inc.
  • Jackson ImmunoResearch Inc.
  • Mabtech AB
  • Merck KGaA
  • Oxford Immunotec USA, Inc.
  • Oy Medix Biochemica Ab
  • ProImmune Ltd.
  • Quansys Biosciences Inc.
  • SBH Sciences
  • U-CyTech BV
  • ZenBio, Inc.
Product Code: MRR-961BA04A2DFA

The ELISpot & FluoroSpot Assay Market was valued at USD 292.68 million in 2023, expected to reach USD 313.61 million in 2024, and is projected to grow at a CAGR of 7.02%, to USD 470.74 million by 2030.

The ELISpot (Enzyme-Linked ImmunoSpot) and FluoroSpot assays are crucial immunological tools widely used in research and clinical settings to measure the frequency of cytokine-secreting cells at a single-cell level. These assays offer highly sensitive and specific quantitative analyses of immune responses, making them invaluable in vaccine development, cancer immunotherapy, and the study of infectious and autoimmune diseases. The necessity of these assays stems from their ability to provide insights into immune status, identify immune correlates of protection, and assist in vaccine efficacy studies. The main application is in immunology research, pharmaceutical companies, and clinical diagnostic laboratories, providing a key market for reagents, consumables, and assay kits.

KEY MARKET STATISTICS
Base Year [2023] USD 292.68 million
Estimated Year [2024] USD 313.61 million
Forecast Year [2030] USD 470.74 million
CAGR (%) 7.02%

Market growth is propelled by increasing research and development activities in immunotherapy and vaccine development, alongside rising healthcare expenditures and favorable government initiatives supporting life sciences research. The advancement in biotechnology enhancing assay sensitivity and throughput, alongside technical improvements like automation, are pivotal growth drivers. However, the primary limitations include high costs of assays, requirement of specialized skill sets, and initial setup expenses which might pose a challenge for market penetration, particularly in developing countries.

For potential business opportunities, companies can focus on offering cost-effective, high-throughput assay solutions, and developing software for data analysis to enhance ease of use and accuracy. Strategic collaborations with research institutions and biopharma companies can bolster market position. Innovation can be directed towards multiplex assays to allow simultaneous detection of multiple cytokines, which is increasingly demanded.

This market shows a trend towards personalized medicine, needing innovations tailored to individual patient immune profiles. Key success will depend on continuous technological advancements and strategic market positioning aimed at overcoming cost and technical barriers, thus ensuring extensive adoption and sustained growth. Companies ideally should invest in R&D to enhance precision, reduce costs, and manage biological complexities, ensuring their offerings align with market needs and technological advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving ELISpot & FluoroSpot Assay Market

The ELISpot & FluoroSpot Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic and infectious diseases
    • Rising need for immunotherapy and personalized medicines
    • Growing usage owing to an increase in immune monitoring studies
  • Market Restraints
    • Complexity and variability of assay protocols
  • Market Opportunities
    • Advancements in the development of user-friendly and high-throughput assay systems
    • High potential of eLISpot & fluoroSpot assay in veterinary applications
  • Market Challenges
    • Interpretation and data analysis complexities with eLISpot & fluoroSpot assays

Porter's Five Forces: A Strategic Tool for Navigating the ELISpot & FluoroSpot Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the ELISpot & FluoroSpot Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the ELISpot & FluoroSpot Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the ELISpot & FluoroSpot Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the ELISpot & FluoroSpot Assay Market

A detailed market share analysis in the ELISpot & FluoroSpot Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the ELISpot & FluoroSpot Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the ELISpot & FluoroSpot Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the ELISpot & FluoroSpot Assay Market

A strategic analysis of the ELISpot & FluoroSpot Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the ELISpot & FluoroSpot Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Anogen-Yes Biotech Laboratories Ltd, Autoimmun Diagnostika GmbH, Becton, Dickinson and Company, Bio-Techne Corporation, BIOSYS Scientific Devices GmbH, BOC Sciences, Broughton Life Sciences Limited, CellCarta Biosciences Inc., Creative Proteomics, Elabscience, Full Moon BioSystems, Inc., Jackson ImmunoResearch Inc., Mabtech AB, Merck KGaA, Oxford Immunotec USA, Inc., Oy Medix Biochemica Ab, ProImmune Ltd., Quansys Biosciences Inc., SBH Sciences, U-CyTech BV, and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the ELISpot & FluoroSpot Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Acessories, Analyzers, and Assay Kits.
  • Based on Application, market is studied across Autoimmune Disorders, Infectious Diseases, Oncology, Organ Transplantation, and Vaccine Development.
  • Based on End-User, market is studied across Academic Research Institutes and Hospitals & Clinical Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic and infectious diseases
      • 5.1.1.2. Rising need for immunotherapy and personalized medicines
      • 5.1.1.3. Growing usage owing to an increase in immune monitoring studies
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity and variability of assay protocols
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the development of user-friendly and high-throughput assay systems
      • 5.1.3.2. High potential of eLISpot & fluoroSpot assay in veterinary applications
    • 5.1.4. Challenges
      • 5.1.4.1. Interpretation and data analysis complexities with eLISpot & fluoroSpot assays
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for comprehensive assay kits among research institutions and laboratories
    • 5.2.2. Application: Expanding government initiatives to propel oncology research, diagnosis, and therapy
    • 5.2.3. End-user: Pertaining use of ELISpot & FluoroSpot assays in research and clinical practices providing unprecedented accuracy and reliable results
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. ELISpot & FluoroSpot Assay Market, by Product

  • 6.1. Introduction
  • 6.2. Acessories
  • 6.3. Analyzers
  • 6.4. Assay Kits

7. ELISpot & FluoroSpot Assay Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Disorders
  • 7.3. Infectious Diseases
  • 7.4. Oncology
  • 7.5. Organ Transplantation
  • 7.6. Vaccine Development

8. ELISpot & FluoroSpot Assay Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Research Institutes
  • 8.3. Hospitals & Clinical Laboratories

9. Americas ELISpot & FluoroSpot Assay Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific ELISpot & FluoroSpot Assay Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa ELISpot & FluoroSpot Assay Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Singamaneni to develop advanced protein imaging method
    • 12.3.2. Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular and Cell Biology Testing
    • 12.3.3. PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Abnova Corporation
  • 3. Agilent Technologies, Inc.
  • 4. Anogen-Yes Biotech Laboratories Ltd
  • 5. Autoimmun Diagnostika GmbH
  • 6. Becton, Dickinson and Company
  • 7. Bio-Techne Corporation
  • 8. BIOSYS Scientific Devices GmbH
  • 9. BOC Sciences
  • 10. Broughton Life Sciences Limited
  • 11. CellCarta Biosciences Inc.
  • 12. Creative Proteomics
  • 13. Elabscience
  • 14. Full Moon BioSystems, Inc.
  • 15. Jackson ImmunoResearch Inc.
  • 16. Mabtech AB
  • 17. Merck KGaA
  • 18. Oxford Immunotec USA, Inc.
  • 19. Oy Medix Biochemica Ab
  • 20. ProImmune Ltd.
  • 21. Quansys Biosciences Inc.
  • 22. SBH Sciences
  • 23. U-CyTech BV
  • 24. ZenBio, Inc.

LIST OF FIGURES

  • FIGURE 1. ELISPOT & FLUOROSPOT ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ELISPOT & FLUOROSPOT ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ELISPOT & FLUOROSPOT ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023